Genelux (GNLX) Shares Outstanding (Diluted Average) (2022 - 2026)

Genelux (GNLX) recorded quarterly Shares Outstanding (Diluted Average) of $44.2 million in Q1 2026, up 18.76% quarter-over-quarter from $37.2 million in Q4 2025, and up 26.41% on a YoY basis from $34.9 million in Q1 2025.

Genelux (GNLX) Shares Outstanding (Diluted Average) (2022 - 2026) Analysis & Trends

Genelux's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $44.2 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 26.41% year-over-year to $44.2 million; the TTM figure through Mar 2026 stood at $44.2 million (up 26.41% YoY), while the FY2025 annual figure was $37.2 million, up 18.21% from the prior year.
  • Shares Outstanding (Diluted Average) was $44.2 million for Q1 2026 at Genelux, up from $37.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $44.2 million in Q1 2026 to a low of $9.1 million in Q4 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $28.2 million across 5 years, with a median of $28.3 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) soared 167.97% in 2023, then gained 6.76% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $9.1 million in 2022, then soared by 167.97% to $24.4 million in 2023, then advanced by 28.74% to $31.5 million in 2024, then climbed by 18.21% to $37.2 million in 2025, then rose by 18.76% to $44.2 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $44.2 million (Q1 2026), $37.2 million (Q4 2025), and $36.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Genelux 129.36 Mn 129.36 Mn - 44.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.15 Mn
Dec 31, 2025 37.18 Mn
Sep 30, 2025 36.87 Mn
Jun 30, 2025 36.35 Mn
Mar 31, 2025 34.93 Mn
Dec 31, 2024 31.45 Mn
Sep 30, 2024 34.53 Mn
Jun 30, 2024 28.31 Mn
Mar 31, 2024 26.85 Mn
Dec 31, 2023 24.43 Mn
Sep 30, 2023 23.64 Mn
Jun 30, 2023 25.07 Mn
Mar 31, 2023 19.58 Mn
Dec 31, 2022 9.12 Mn
Sep 30, 2022 10.07 Mn